InvestSMART

Pacific Edge Limited (ASX: PEB) - Announcements

- Current share price for PEB : $0.190

ASX company news and announcements for Pacific Edge Limited (PEB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Pacific Edge Limited (PEB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Pacific Edge Limited (PEB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Pacific Edge Limited (PEB)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$236 Trading Halt 5 Jun 2023 8:54AM $0.380 $0.190 fallen by 50%
$236 Clarification of Novitas Timeline 2 Jun 2023 7:31AM $0.380 $0.190 fallen by 50%
$236 Pacific Edge Delivers on Growth Strategy in FY 2023 25 May 2023 8:25AM $0.380 $0.190 fallen by 50%
$236 Director Nomination Closing Date 22 May 2023 1:45PM $0.380 $0.190 fallen by 50%
$236 Notification regarding unquoted securities - PEB 3 May 2023 10:54AM $0.418 $0.190 fallen by 54.49%
$236 Capital Change Notice - NZX 3 May 2023 10:51AM $0.418 $0.190 fallen by 54.49%
$236 Pacific Edge Full Year Result to be Announced 25 May 2023 1 May 2023 11:16AM $0.418 $0.190 fallen by 54.49%
$236 Quarterly Update Q4 23 Test Volumes Reach New Record 18 Apr 2023 7:34AM $0.380 $0.190 fallen by 50%
$236 Pacific Edge Provides Update on Kaiser EMR Integration 31 Mar 2023 7:34AM $0.380 $0.190 fallen by 50%
$236 Quarterly Investor Update - Q3 FY23 Test Volumes rise 36% 19 Jan 2023 7:46AM $0.475 $0.190 fallen by 60%
$236 Te Whatu Ora - Southern Commercial Agreement Completed 13 Jan 2023 8:04AM $0.475 $0.190 fallen by 60%
$236 Notification regarding unquoted securities - PEB 22 Dec 2022 7:47AM $0.450 $0.190 fallen by 57.78%
$236 Application for quotation of securities - PEB 21 Dec 2022 2:45PM $0.450 $0.190 fallen by 57.78%
$236 Notification of cessation of securities - PEB 21 Dec 2022 11:58AM $0.430 $0.190 fallen by 55.81%
$236 NZX D&O Disclosures - P Meintjes & G Gibson 21 Dec 2022 11:13AM $0.430 $0.190 fallen by 55.81%
$236 Capital Change Notice - NXZ 21 Dec 2022 11:11AM $0.430 $0.190 fallen by 55.81%
$236 Capital Change Notice - NZX 21 Dec 2022 11:10AM $0.430 $0.190 fallen by 55.81%
$236 Enhanced Cxb Tests Deliver Improved Diagnostic Performance 13 Dec 2022 7:33AM $0.415 $0.190 fallen by 54.22%
$236 Financial Results for the Half Year to 30 September 2022 24 Nov 2022 7:32AM $0.410 $0.190 fallen by 53.66%
$236 Interim Financial Results to be Announced 24 November 2022 11 Nov 2022 7:31AM $0.400 $0.190 fallen by 52.50%
$236 Quarterly Investor Update - Q2 FY23 Test Volumes rise 36% 17 Oct 2022 7:34AM $0.405 $0.190 fallen by 53.09%
$236 Letter to Shareholders 17 Oct 2022 7:31AM $0.405 $0.190 fallen by 53.09%
$236 Update on Te Whatu Ora Southern Commercial Agreement 23 Sep 2022 7:32AM $0.410 $0.190 fallen by 53.66%
$236 PACIFIC EDGE COMMENTS ON PROPOSED NOVITAS LCD 1 Aug 2022 8:39AM $0.660 $0.190 fallen by 71.21%
$236 Trading Halt 29 Jul 2022 10:19AM $0.660 $0.190 fallen by 71.21%

176 - 200 of 268 results

Page 8 of 11

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.